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Abstract
Background: Autosomal recessive congenital ichthyosis (ARCI) is a genetically 
and phenotypically heterogeneous skin disease, associated with defects in the skin 
permeability barrier. Several but not all genes with underlying mutations have been 
identified, but a clear correlation between genetic causes and clinical picture has not 
been described to date.
Methods: Our study included 19 families from Saudi Arabia, Yemen, and Pakistan. 
All patients were born to consanguineous parents and diagnosed with ARCI. 
Mutations were analyzed by homozygosity mapping and direct sequencing.
Results: We have detected mutations in all families in five different genes: TGM1, 
ABCA12, CYP4F22, NIPAL4, and ALOXE3. Five likely pathogenic variants were 
unknown so far, a splice site and a missense variant in TGM1, a splice site variant in 
NIPAL4, and missense variants in ABCA12 and CYP4F22. We attributed TGM1 and 
ABCA12 mutations to the most severe forms of lamellar and erythematous 
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1 |  INTRODUCTION
The skin barrier is imperative for protecting the organism 
from internal water loss as well as from outside pathogens 
and toxic compounds. Defects in the skin barrier function 
can lead to several skin disorders including autosomal reces-
sive congenital ichthyosis (ARCI) (Feingold & Elias, 2014; 
Schmuth et al., 2013; Traupe, Fischer, & Oji, 2014).
Autosomal recessive congenital ichthyosis (MIM 242300, 
242100, 606545, 601277, 242500, 604777, 612281, 615022, 
613943, 615023, 602400, 615024, 617320, 617574, 617571) 
refers to a group of nonsyndromic congenital ichthyoses that 
include Harlequin ichthyosis (HI), lamellar ichthyosis (LI), 
and congenital ichthyosiform erythroderma (CIE) (Oji et al., 
2010). Even though ARCI is a very heterogeneous disorder, 
common features include a generalized scaling of the skin, 
often with underlying erythema. Newborns usually present a 
collodion membrane that is lost during the first weeks of life. 
To date, 12 genes have been associated with ARCI: TGM1 
(MIM 190195), ALOX12B (MIM 603741), ALOXE3 (MIM 
607206), ABCA12 (MIM 607800), CYP4F22 (MIM 611495), 
NIPAL4 (MIM 609383), LIPN (MIM 613924), CERS3 (MIM 
615276), PNPLA1 (MIM 612121), CASP14 (MIM 605848), 
SDR9C7 (MIM 609769), and SULT2B1 (MIM 604125), and 
at least 10%–15% of affected individuals do not have muta-
tions in any of the known genes (Hellström Pigg et al., 2016; 
Vahlquist, Fischer, & Törmä, 2018). These genes have been 
linked to the maintenance of skin barrier function as their 
products are involved in the formation of the cornified lipid 
envelope in the stratum corneum and ceramide formation 
and processing in the epidermis (Eckl et al., 2013; Li, Loriè, 
Fischer, Vahlquist, & Törmä, 2012; Ohno et al., 2015).
HI is the most severe and often fatal form of the disease. 
Truncating mutations in ABCA12 have been detected as the 
main cause for HI (Akiyama, 2014; Akiyama et al., 2005). LI 
and CIE, in contrast, have not yet been associated with a clear 
genotype/phenotype correlation. Patients with LI exhibit 
large, thick scales over the entire body without a severe back-
ground erythroderma. Patients with CIE normally present 
fine, whitish scales as well as generalized erythroderma. Both 
clinical forms can show partially overlapping phenotypes, 
ranging from coarse to fine scaling and mild to severe ery-
thema (Rodriguez‐Pazos, Ginarte, Vega, & Toribio, 2013). 
In more than 50% of the patients, LI is caused by mutations 
in TGM1, however, TGM1 mutations have also been reported 
to cause CIE (Becker et al., 2003; Herman et al., 2009), as 
well as other subtypes of ARCI, such as bathing suit ich-
thyosis (BSI) and self‐improving ichthyosis (SII) (Hackett, 
Fitzgerald, Watson, Hol, & Irvine, 2010; Raghunath et al., 
2003). SII refers to a patient who is born with a collodion 
membrane but presents only a particularly mild phenotype 
after the first weeks of life.
Mutations in ALOXE3 and ALOX12B, that code for lip-
oxygenases eLOX‐3 and 12R‐LOX, and NIPAL4 have been 
associated to LI, CIE and also SII (Eckl et al., 2009; Jobard et 
al., 2002; Vahlquist et al., 2010). Other ARCI genes include 
cytochrome P450 member CYP4F22, which encodes a fatty 
acid hydroxylase (Ohno et al., 2015), and defects of this gene 
have been linked to LI (Lefevre et al., 2006). Mutations in 
CERS3, PNPLA1, SDR9C7, and SULT2B1, have been identi-
fied in few families with ARCI presenting mainly LI pheno-
types (Eckl et al., 2013; Grall et al., 2012; Heinz et al., 2017; 
Israeli et al., 2011; Shigehara et al., 2016).
We present the findings of a study that involved 19 consan-
guineous families from Saudi Arabia, Yemen, and Pakistan 
with affected members diagnosed with different forms of 
ARCI. For all of them, we have identified the underlying 
mutations causing the disease, using homozygosity mapping 
combined with Sanger sequencing. We have detected eleven 
different mutations in various ARCI‐associated genes, five of 
which are being reported for the first time.
2 |  MATERIALS AND METHODS
2.1 | Ethical compliance
All procedures involving human participants were ap-
proved by institutional Research Ethics Committees and in 
ichthyoses, respectively, regardless of treatment. Other mutations highlighted the 
presence of a phenotypic spectrum in ARCI.
Conclusion: Our results contribute to expanding the mutational spectrum of ARCI 
and revealed new insights into genotype/phenotype correlations. The findings are 
instrumental for a faster and more precise diagnosis, a better understanding of the 
pathophysiology, and the definition of targets for more specific therapies for ARCI.
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   | 3 of 12LIMA CUNHA et AL.
T
A
B
L
E
 1
 
Pa
tie
nt
 in
fo
rm
ati
on
 an
d c
lin
ica
l d
iag
no
sis
Pa
tie
nt
Ge
nd
er
Bi
rth
 
ye
ar
Af
fec
ted
 
in
 fa
m
ily
Or
igi
n
Cl
in
ica
l 
di
ag
no
sis
Ph
en
ot
yp
ic 
fea
tu
re
s
Tr
ea
tm
en
t
Sc
ali
ng
Er
yt
he
m
a
SA
‐0
1
M
19
97
1
Sa
ud
i A
ra
bi
a
LI
Se
ve
re
, g
en
er
ali
ze
d;
 co
ar
se
 br
ow
n s
ca
les
; p
alm
op
lan
tar
 hy
pe
rk
er
ato
sis
No
Ac
itr
eti
n (
3–
4 y
ea
rs,
 11
–2
0 m
g)
SA
‐0
2
M
19
94
2
Sa
ud
i A
ra
bi
a
CI
E
Se
ve
re
, g
en
er
ali
ze
d;
 fi
ne
 w
hi
te 
sc
ale
s; 
pa
lm
op
lan
tar
 hy
pe
rk
er
ato
sis
Se
ve
re
‐
SA
‐0
4
F
19
95
1
Sa
ud
i A
ra
bi
a
LI
Se
ve
re
 ge
ne
ra
liz
ed
; c
oa
rse
 br
ow
n s
ca
les
; p
alm
op
lan
tar
 hy
pe
rk
er
ato
sis
No
Ac
itr
eti
n (
11
–1
5 y
ea
rs,
 
21
–3
0 m
g)
SA
‐0
5
F
20
07
1
Sa
ud
i A
ra
bi
a
LI
Se
ve
re
 ge
ne
ra
liz
ed
; c
oa
rse
 br
ow
n s
ca
les
; p
alm
op
lan
tar
 hy
pe
rk
er
ato
sis
No
Ac
itr
eti
n (
1–
2 y
ea
rs,
 5–
10
 m
g)
SA
‐0
6
F
19
99
2
Sa
ud
i A
ra
bi
a
LI
Se
ve
re
 ge
ne
ra
liz
ed
; c
oa
rse
 br
ow
n s
ca
les
; p
alm
op
lan
tar
 hy
pe
rk
er
ato
sis
No
Ac
itr
eti
n (
1–
4 w
ee
ks
, 5
–1
0 m
g)
SA
‐0
8
F
19
86
1
Sa
ud
i A
ra
bi
a
LI
M
ild
 ge
ne
ra
liz
ed
; f
in
e l
ig
ht
 br
ow
n s
ca
les
; p
lan
tar
 hy
pe
rk
er
ato
sis
M
ild
Ac
itr
eti
n (
5–
6 y
ea
rs,
 5–
10
 m
g)
SA
‐0
9
M
20
03
2
Sa
ud
i A
ra
bi
a
LI
M
od
er
ate
 ge
ne
ra
liz
ed
; f
in
e l
ig
ht
 br
ow
n s
ca
les
; p
lan
tar
 hy
pe
rk
er
ato
sis
No
NA
SA
‐1
0
M
20
03
2
Sa
ud
i A
ra
bi
a
LI
M
od
er
ate
 ge
ne
ra
liz
ed
; c
oa
rse
, l
ar
ge
 li
gh
t b
ro
wn
 sc
ale
s; 
pl
an
tar
 hy
pe
rk
er
ato
sis
No
‐
SA
‐1
1
F
20
05
1
Sa
ud
i A
ra
bi
a
LI
Se
ve
re
 ge
ne
ra
liz
ed
; c
oa
rse
, l
ar
ge
 li
gh
t b
ro
wn
 sc
ale
s; 
pl
an
tar
 hy
pe
rk
er
ato
sis
No
‐
SA
‐1
2
M
20
10
1
Sa
ud
i A
ra
bi
a
LI
Se
ve
re
 ge
ne
ra
liz
ed
; c
oa
rse
, l
ar
ge
 li
gh
t b
ro
wn
, p
lat
e‐
lik
e s
ca
les
; p
alm
op
lan
tar
 
hy
pe
rk
er
ato
sis
No
‐
SA
‐1
3
F
20
06
2
Sa
ud
i A
ra
bi
a
SI
I
No
No
‐
SA
‐1
4
M
20
06
1
Sa
ud
i A
ra
bi
a
LI
Se
ve
re
 ge
ne
ra
liz
ed
 sc
ali
ng
; c
oa
rse
 an
d l
ar
ge
 br
ow
n s
ca
les
; p
alm
op
lan
tar
 
hy
pe
rk
er
ato
sis
No
Ac
itr
eti
n (
3–
4 y
ea
rs,
 5–
10
 m
g)
SA
‐1
5
M
20
07
1
Sa
ud
i A
ra
bi
a
LI
M
od
er
ate
, m
or
e p
re
se
nt
 in
 up
pe
r b
od
y;
 co
ar
se
, l
ar
ge
 li
gh
t b
ro
wn
 sc
ale
s; 
pl
an
tar
 
hy
pe
rk
er
ato
sis
No
‐
YE
‐0
1
F
20
06
1
Ye
m
en
LI
Se
ve
re
, g
en
er
ali
ze
d;
 co
ar
se
 br
ow
n s
ca
les
; p
alm
op
lan
tar
 hy
pe
rk
er
ato
sis
No
‐
PK
01
‐0
1
F
NA
4
Pa
ki
sta
n
CI
Ge
ne
ra
liz
ed
 sc
ali
ng
, m
or
e v
isi
bl
e i
n h
an
ds
, n
ec
k a
nd
 fa
ce
; f
in
e l
ig
ht
‐c
ol
or
ed
 sc
ale
s
M
od
er
ate
NA
PK
01
‐0
2
M
NA
NA
PK
02
‐0
1
F
NA
2
Pa
ki
sta
n
CI
Sc
ali
ng
 m
or
e s
ev
er
e i
n f
ac
e, 
ne
ck
 an
d h
an
ds
; c
oa
rse
 br
ow
ni
sh
 sc
ale
s
No
NA
PK
02
‐0
2
M
NA
NA
PK
03
‐0
1
M
NA
2
Pa
ki
sta
n
CI
M
or
e v
isi
bl
e i
n h
an
ds
, n
ec
k a
nd
 fa
ce
; f
in
e l
ig
ht
er
‐c
ol
or
ed
, y
ell
ow
ish
 sc
ale
s
M
od
er
ate
NA
PK
03
‐0
4
M
NA
4
PL
Sa
Se
ve
re
 lo
ca
liz
ed
 in
 ha
nd
s, 
fe
et,
 kn
ee
s; 
na
il 
an
d t
ee
th
 m
alf
or
m
ati
on
; t
ra
ns
gr
ed
ien
t 
hy
pe
rk
er
ato
sis
No
NA
PK
04
‐0
1
M
NA
1
Pa
ki
sta
n
CI
Sc
ali
ng
 lo
ca
liz
ed
 vi
sib
le 
in
 ha
nd
s, 
ne
ck
 an
d f
ac
e; 
lig
ht
er
‐c
ol
or
ed
 an
d l
es
s c
om
pa
ct 
sc
ale
s
M
od
er
ate
NA
PK
05
‐0
1
M
NA
5
Pa
ki
sta
n
CI
Sc
ali
ng
 m
or
e s
ev
er
e i
n f
ac
e, 
ne
ck
 an
d h
an
ds
; c
oa
rse
 br
ow
ni
sh
 sc
ale
s
No
NA
PK
05
‐0
3
F
NA
NA
PK
05
‐0
4
M
NA
NA
N
ot
e. 
CI
: C
on
ge
ni
tal
 ic
ht
hy
os
is;
 C
IE
: C
on
ge
ni
tal
 ic
ht
hy
os
ifo
rm
 er
yt
hr
od
er
m
a; 
LI
: L
am
ell
ar
 ic
ht
hy
os
is;
 N
A:
 in
fo
rm
ati
on
 no
t a
va
ila
bl
e; 
PL
S:
 P
ap
ill
on
–L
ef
èv
re
 sy
nd
ro
m
e; 
SI
I: 
Se
lf‐
im
pr
ov
in
g i
ch
th
yo
sis
.
a O
n r
ein
ve
sti
ga
tio
n f
ol
lo
wi
ng
 m
ol
ec
ul
ar
 an
aly
sis
. 
4 of 12 |   LIMA CUNHA et AL.
accordance with the 1964 Helsinki declaration and its later 
amendments. Informed consent was obtained from all indi-
vidual participants included in the study.
2.2 | Patients and phenotypic features
Samples from a total of 37 individuals diagnosed with dif-
ferent forms of ARCI and 72 unaffected members were 
collected. We have studied 19 consanguineous families, 13 
from Saudi Arabia, 1 from Yemen, and 5 from Pakistan. At 
least one affected individual (index case) from each pedi-
gree was tested by homozygosity mapping. The detailed 
clinical features of all index cases are shown in Table 1 
and Figure 1.
Affected individuals were clinically diagnosed with 
different forms of ARCI by experienced dermatologists 
and presented heterogeneous phenotypes. The majority of 
Saudi Arabian (SA) patients and the Yemenite (YE) patient 
showed a phenotype of LI, with generalized scaling and 
mild to no erythema. SA‐02 was the only patient with severe 
erythema and was hence diagnosed with CIE. SA‐13 was 
diagnosed with SII, as she presented no scaling or erythema 
but was reported to have had a collodion membrane at birth. 
Some patients were being treated with the retinoid acitretin, 
which modulates keratinocyte differentiation, at the time of 
the sample collections, but with different durations, ranging 
from few weeks to nearly 15 years of treatment.
Pakistani affected individuals (PK) showed more appar-
ent generalized and severe localized scaling. The families 
had limited access to medical care and no pharmacological 
treatment options. Patients from families PK01 and PK04 
presented moderate erythema. Family PK03 (Supporting 
information Figure S1) showed more dissimilar phenotypes 
among the patients: patient PK03‐01 had a more generalized 
but less severe scaling phenotype but patient PK03‐04 pre-
sented with more localized and severe scaling on hands and 
feet associated with visible tooth and nail malformations(-
Figure 1h,i).
2.3 | Homozygosity mapping
Genomic DNA was extracted from peripheral blood or 
saliva samples with standard methods. Homozygosity 
mapping was performed in samples of index patients using 
HumanCytoSNP‐12 (Illumina, San Diego, CA, USA), follow-
ing the manufacturer's instructions. Generated data were ana-
lyzed with Nexus Copy Number™ software (BioDiscovery, 
Hawthorne CA, USA). The longest regions of homozygosity 
were extracted for each index case and compared to the loca-
tions of known ARCI genes.
2.4 | Sanger sequencing
Target exons were amplified by PCR using standard cycle 
conditions and in‐house designed primers (primers lists avail-
able upon request). Products were sequenced using BigDye 
Terminator v1.1 kit (Applied Biosystems, Foster City, CA, 
USA) and run on a Sequence Analyzer 3130XL (Applied 
Biosystems).
2.5 | Next‐generation sequencing
Two index patients with a homozygous region matching 
ABCA12 location were further analyzed with a custom‐made 
dermatogenetics gene panel comprising 56 genes including 
all known ARCI genes using an Illumina HiSeq sequencing 
system (Illumina).
Because no homozygous mutation was found in any 
known ARCI gene in PK03‐04, in contrast to his nephew 
PK03‐01, exome sequencing was performed using enrich-
ment with SureSelect Human All Exon V6 (Agilent, Santa 
Clara, CA) and a HiSeq sequencing system (Illumina). Data 
analysis of filter‐passed reads was done with BWA‐short in 
combination with GATK and SAMTOOLS as implemented 
in the in‐house analysis tool Varbank (Cologne Center for 
Genomics).
2.6 | In silico data analysis
Sequences were analyzed with SeqmanPro (DNASTAR Inc., 
Madison, WI, USA). Unknown missense variants were re-
garded as likely pathogenic if they were predicted to be dam-
aging by at least two of the algorithms MutTaster (Schwarz, 
Cooper, Schuelke, & Seelow, 2014), SIFT (Kumar, Henikoff, 
& Ng, 2009) and PolyPhen‐2 (Adzhubei et al., 2010), af-
fected highly conserved amino acids, and were not found as 
F I G U R E  1  Clinical features of patients with ARCI, categorized by mutant genes. (a–c) TGM1 affected patients showed generalized severe, 
dark colored scales, and palmoplantar hyperkeratosis, apparently independent of type of mutation or treatment. (d) Patient diagnosed with SII, 
with no visible skin alterations at 6 years of age. (e–f) Patients with NIPAL4 splice site (e) and missense (f) mutations presented a variable range 
of symptoms like milder to moderate scaling more prominent in the upper body half but no palmar hyperkeratosis. (g–h) Patients with ABCA12 
mutations with fine to medium‐sized whitish scaling and erythema (SA‐02), and with slightly milder phenotype and white scales (PK01). (i) 
Patients from families PK04 and PK03 with generalized whitish scaling, quite visible on the hands, diagnosed with ALOXE3 nonsense mutations. 
(j) Affected individuals from another branch of family PK03, initially also diagnosed with ARCI. Upon reinvestigation, they showed more localized 
severe scaling on the hands and feet as well as nail and teeth (not shown) anomalies consistent with a diagnosis of Papillon–Lefèvre syndrome 
caused by CTSC mutation
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homozygous variants in control DNA sequences as analyzed 
by the Exome Aggregation Consortium (exac.broadinstitute.
org) and the 1,000 Genomes Project (www.internationalge-
nome.org). Splice site variants were analyzed with Human 
Splicing Finder 3.0 (Desmet et al., 2009). Protein domains 
were determined using PFAM (Finn, Coggill, Eberhardt, & 
Eddy, 2016).
2.7 | GenBank Accession numbers
TGM1: NM_00359.2/NP_000350.1
NIPAL4: NM_001099287.1/NP_001092757.1
ABCA12: NM_173076.2/NP_775099.2.
CYP4F22: NM_173483.3/NP_775754.2.
ALOXE3: NM_001165960.1/NP_001159432.1
CTSC: NM_001814.4/NP_001805.3
3 |  RESULTS
DNA samples from 13 unrelated ARCI families from Saudi 
Arabia, one from Yemen as well as five extended families 
from Pakistan were used in this study to investigate the ge-
netic causes of ARCI. After aligning the location of known 
ARCI genes with regions of homozygosity obtained from 
genome‐wide homozygosity mapping, one to three can-
didate intervals containing one or two of these genes each 
were found for all index cases (Supporting information Table 
S1). Mutations were identified with conventional direct se-
quencing of candidate genes, except for ABCA12, which 
comprises 53 exons and was therefore analyzed with gene 
panel sequencing. Homozygous causal mutations were found 
for each index case, and co‐segregation of mutations with 
phenotypes was confirmed in all available family members. 
Previously unknown variants in ARCI genes were assessed 
in silico and classified as defined in Methods. A summary of 
the mutations is shown in Table 2.
3.1 | Families from Saudi 
Arabia and Yemen
Mutations in TGM1 were the most common in this study, 
found in seven of the thirteen index patients from Saudi 
Arabia. Aside from SA‐13 diagnosed with SII, all patients 
with TGM1 mutations had been diagnosed with LI and 
presented with similar clinical features (Figure 1a‐d). SA‐01, 
SA‐06, SA‐12, SA‐14, and YE‐01 had the same homozy-
gous duplication c.398_407dupAGTATGAGTA in exon 3, 
which leads to a premature stop codon (p.Tyr136*). This 
mutation has been linked to two ARCI families from Saudi 
Arabia (Wakil et al., 2016), pointing to a potential founder 
mutation on the Arabian Peninsula. SA‐04, also diagnosed 
with LI, presented a missense change in exon 9, c.1340A>C 
(p.Asp447Ala). This variant is located within the catalytic 
core of transglutaminase 1 (Figure 2b). A splice acceptor 
site change c.758‐1G>C in intron 4 of TGM1 was found in 
SA‐05 (Figure 2a). Patient SA‐13, diagnosed with SII based 
on the lack of signs for congenital ichthyosis aside from the 
presence of a collodion membrane at birth, presented a ho-
mozygous missense variant in exon 5 of TGM1, c.871G>A 
(p.Gly291Ser). This variant was previously reported in a 
Japanese LI patient with compound heterozygosity, which 
might explain the different forms of the disease (Sakai et al., 
2009). This finding is in accordance with Hackett et al, who 
reviewed the phenotypes associated with more than 40 mu-
tations reported in TGM1 and noted that mutations associ-
ated with SII seemed to cluster in exons 5, 6, and 7 of TGM1 
(Hackett et al., 2010).
Four patients diagnosed with LI (SA‐08, SA‐09, SA‐10, 
and SA‐11) presented a common, previously unreported ho-
mozygous intronic deletion of 18 nucleotides in NIPAL4, 
c.223+5_223+22delGTACGGCAGGGCTGGGGA, which 
is predicted to affect the donor splice site of intron 1 (Figure 
2c).
SA‐02, a patient diagnosed with CIE, was found to 
have a homozygous missense variant, c.4541G>T (p.Ar-
g1514Leu), in exon 30 of ABCA12 (Figure 2d). SA‐15, 
diagnosed with LI, has a missense variant c.982G>A (p.
Glu328Lys) in exon 9 of CYP4F22, which has not been 
described before (Figure 2e). This variant was predicted as 
deleterious and is located inside the predicted cytochrome 
P450 domain.
3.2 | Families from Pakistan
We found a homozygous missense variant in exon 31 of 
ABCA12, c.4676G>T (p.Gly1559Val), in family PK01. 
Nawaz et al described this variant before in a consanguine-
ous family from Pakistan with non‐bullous CIE (Nawaz et 
al., 2012).
F I G U R E  2  Family pedigrees and sequences of unknown mutations identified in this study. Pedigrees show index patients used for 
homozygosity mapping marked with a black outlined arrow (↑) and all samples confirmed by Sanger sequencing marked with a star (*). All parents 
of patients have a consanguinity relation. At least one parent is included in the displayed sequences to demonstrate co‐segregation. Red arrows 
indicate the positions of nucleotide substitutions or deletions. In the reference sequences, uppercase letters indicate exon nucleotides and lowercase 
letters intronic bases. (a) Examples of two Saudi Arabian pedigrees with patients with a homozygous intronic deletion in intron 1 of NIPAL4. (b) 
A homozygous missense mutation c.1340A>C was detected in exon 9 of TGM1 in SA‐04. (c) Patient SA‐05 was identified with a homozygous 
mutation in the acceptor splice site of TGM1 intron 4. (d) A previously unknown missense mutation in exon 9 of CYP4F22 was found in SA‐15
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Patients from families PK02 and PK05 were identified 
with the same homozygous missense variant c.527C>A 
(p.Ala176Asp) in exon 4 of NIPAL4. This variant was re-
ported before (Lefevre et al., 2004) and is located within the 
suggested transporter domain of the NIPAL4 protein.
A homozygous nonsense mutation, c.814C>T 
(p.Arg272*), in exon 4 of ALOXE3 was found in patients of 
family PK04. The mutation was reported in a Pakistani fam-
ily diagnosed with CIE (Ullah et al., 2016).
Homozygosity mapping in index cases of family 
PK03 (Supporting information Figure S1) showed a ho-
mozygous region matching the ALOXE3/ALOX12B genes 
location, and Sanger sequencing revealed the same homo-
zygous mutation as seen in PK04, c.814C>T (p.Arg272*) 
in ALOXE3, in one branch of the family. However, af-
fected individuals from another branch were either het-
erozygous for the mutation or even homozygous for the 
reference allele. Reinvestigation demonstrated that these 
patients were also affected with nail malformation and 
early loss of teeth and the skin lesions were more lim-
ited to the extremities, in contrast to PK03‐01 and his 
affected sister. PK03‐04 was then analyzed by exome 
sequencing and the likely pathogenic variant c.901G>A 
(p.Gly301Ser) in CSTC, the gene encoding cathepsin C, 
was found.
4 |  DISCUSSION
Using a combination of homozygosity mapping and candidate 
gene sequencing, we identified eleven different mutations in 
five genes in a total of 19 consanguineous families with ARCI 
from Saudi Arabia, Yemen, and Pakistan. All variants were 
classified as pathogenic or likely pathogenic and were ho-
mozygous as expected, and thus represent a particularly use-
ful resource to search for genotype/phenotype correlations, 
although the clinical appearance was different between Saudi 
Arabian and Pakistani patients based on the level of medical 
care available. All patients with TGM1 mutations, except SII‐
diagnosed SA‐13, presented the most severe phenotypes, with 
generalized coarse brown scaling (Figure 1a–d). Interestingly, 
this phenotype seems independent of the type of mutation 
and even prominent after oral treatment with acitretin. Two 
unknown disease‐causing mutations were found in TGM1: 
p.Asp447Ala (c.1340A>C) in exon 9 and c.758‐1G>C at the 
splice acceptor site of intron 4. Even after treatment with ac-
itretin for approximately 15 years, the patient with mutation 
p.Asp447Ala presented a severe phenotype, similar to non‐
treated patients with TGM1 mutations. The second mutation 
was found in a patient with LI and a similar phenotype with 
severe scaling and rough and brownish scales.
F I G U R E  3  Schematic representation of genotype/phenotype correlations of ARCI found in this study. All phenotypes and genotypes were 
grouped according to our findings. Each index case is named and boxed according to the severity of the scaling (X axis) and its extension (Y 
axis). Types of mutations are indicated by the shape of the boxes, that is, squares for missense, oval for nonsense, and diamonds for splice site 
mutations. Scaling type was also included, with coarse scales represented by a full‐outline box and fine scales by dashed outlines. Patients with an 
erythematous phenotype are represented by an asterisk (*) and those treated with acitretin are underlined
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In contrast, the patients from the Saudi Arabian co-
hort carrying the same NIPAL4 intronic deletion, 
c.223+5_223+22delGTACGGCAGGGCTGGGGA, showed 
variable phenotypes, ranging from mild to severe general-
ized scaling, with white to light brown‐colored scales, fine or 
coarse. SA‐08 had the mildest symptoms, with mild scaling 
and skin dryness, likely improved by the treatment with ac-
itretin. On the other hand, SA‐11 was never treated with ac-
itretin and presented the most severe phenotype in this group, 
with coarse light brown scales and severe scaling and dry-
ness (Figure 1e). Patient SA‐15 with a CYP4F22 mutation, 
also diagnosed with LI, presented moderate skin dryness and 
more localized scaling in the face, neck, abdomen, back, and 
arms (photos not available).
SA‐02, diagnosed with CIE and with the unreported 
ABCA12 missense mutation p.Arg1514Leu (c.4541G>T), 
presented a severe skin phenotype, including generalized se-
vere scaling with fine white scales, pronounced erythema and 
palmoplantar keratoderma (Figure 1g). A homozygous G to 
A change at the same position leading to p.Arg1514His was 
described in ARCI before (Lefevre et al., 2003).
Notably, we identified two autosomal recessive skin dis-
orders in the same consanguineous family, PK03, initially di-
agnosed only with ARCI. A homozygous nonsense mutation 
in exon 4 of ALOXE3 was found in index patient PK03‐01 
and segregation was confirmed by analysis of the parents and 
siblings. The phenotype of PK03‐01 also matched the pheno-
type of PK04‐01 who showed the same mutation (Figure 1h). 
However, the index patient PK03‐04 of the second branch 
of the family and his affected siblings, initially diagnosed 
with ARCI, showed localized scaling mostly on hands and 
feet associated with nail malformations and teeth loss at an 
early age on reinvestigation (Figure 1i). They did not carry 
the homozygous ALOXE3 mutation, and exome sequencing 
revealed a homozygous mutation in CTSC, which was previ-
ously reported in patients with Papillon–Lefèvre syndrome 
(PLS) (Nagy et al., 2014; Noack et al., 2008; Toomes et al., 
1999). PLS (MIM #245000) is a rare autosomal recessive 
condition presenting diffuse keratoderma together with rap-
idly progressive periodontitis (Dhanrajani, 2009). This find-
ing confirmed two different diagnoses of ARCI and PLS, 
respectively, in two branches of the family (Supporting infor-
mation Figure S1).
The identification of various homozygous mutations in 
different genes facilitated an important contribution to de-
fining a genotype/phenotype correlation for ARCI (Figure 
3). Mutations in TGM1 and ABCA12 cause the most severe 
phenotypes, compared to NIPAL4, CYP4F22, and ALOXE3 
mutations. We could also establish parameters regarding the 
color and appearance of the scales, where patients with de-
fects in TGM1 seem to present the darkest and coarsest scales, 
followed by CYP4F22, NIPAL4 and lastly ALOXE3, which 
ranged from light brown to white. ABCA12 affected patients 
presented the lightest colored scales, all of them white and 
fine. Furthermore, all Saudi Arabian patients showed palmar 
hyperlinearity but only TGM1 and ABCA12 affected individ-
uals presented palmoplantar hyperkeratosis, while NIPAL4 
and CYP4F22 presented only plantar keratosis.
Our study demonstrated that homozygosity mapping cou-
pled with Sanger sequencing is still a valid and cost‐efficient 
tool to identify rare disease‐causing mutations in consan-
guineous families. While establishing a genotype/phenotype 
correlation for ARCI patients is a difficult task, our findings 
have added strong and new insights to this matter, hopefully 
leading to a better clinical and molecular understanding of 
this heterogeneous disease and to novel approaches for patho-
physiology‐based therapies.
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